Integer Holdings Corp
NYSE:ITGR
Integer Holdings Corp
Non-Reccuring Items
Integer Holdings Corp
Non-Reccuring Items Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Non-Reccuring Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
I
|
Integer Holdings Corp
NYSE:ITGR
|
Non-Reccuring Items
-$15.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-1%
|
CAGR 10-Years
0%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Non-Reccuring Items
-$480m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-36%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Non-Reccuring Items
-$402m
|
CAGR 3-Years
24%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
11%
|
|
|
Stryker Corp
NYSE:SYK
|
Non-Reccuring Items
-$1.4B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-3%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Non-Reccuring Items
-$350m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
N/A
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Non-Reccuring Items
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Integer Holdings Corp
Glance View
Integer Holdings Corporation, a prominent player in the medical device industry, has carved a significant niche by aligning innovation with robust manufacturing capabilities. Founded as a collaborative effort between technical ingenuity and healthcare innovation, Integer primarily engages in the design and production of medical devices and components that are instrumental for the med-tech sector. It serves a diverse clientele that ranges from large healthcare conglomerates to emerging med-tech companies. The company operates through two main segments: Medical and Non-Medical. In the Medical division, Integer excels by providing critical components used in cardiac rhythm management, neuromodulation, and vascular access. It thrives on the premise that precision in manufacturing and innovation are key to producing reliable and effective medical solutions, ensuring that they meet stringent regulatory standards. What truly propels Integer’s financial engine is its commitment to operational excellence and strategic partnerships. By integrating vertically across its production processes, Integer achieves cost efficiencies that allow it to offer competitive pricing without sacrificing quality. Moreover, the company extends its influence through strategic partnerships with prominent healthcare providers, thereby securing long-term contracts and steady revenue streams. This model is supplemented by its Non-Medical segment, where Integer provides high-reliability components for energy, military, and environmental applications. These ventures not only diversify its revenue portfolio but also bolster its resilience against market volatility. Integer’s growth narrative is underscored by a relentless focus on research and development, which facilitates continuous product enhancement and keeps it at the forefront of technological advancement in the medical device industry. Through these strategies, Integer Holdings Corporation not only sustains its market position but also expands its role as a critical enabler in the global healthcare landscape.
See Also
What is Integer Holdings Corp's Non-Reccuring Items?
Non-Reccuring Items
-15.4m
USD
Based on the financial report for Dec 31, 2024, Integer Holdings Corp's Non-Reccuring Items amounts to -15.4m USD.
What is Integer Holdings Corp's Non-Reccuring Items growth rate?
Non-Reccuring Items CAGR 10Y
0%
Over the last year, the Non-Reccuring Items growth was 23%.
You don't have any saved screeners yet